Theranos once captivated Silicon Valley’s biotech sector with its bold claim that a comprehensive array of medical tests could be conducted using just a single drop of blood. After raising massive amounts of capital, the company spectacularly imploded in one of the tech world's most notorious fraud cases. Now, You Can See Everything, a new documentary focusing on founder Elizabeth Holmes, is drawing widespread attention.
The film offers an objective re-examination of just how severely Theranos’s technological approach diverged from scientific reality. In particular, it scrutinizes the structural flaws of Silicon Valley's celebrated "fake it 'til you make it" ethos, unpacking the disastrous consequences that arise when such a mentality is applied to healthcare—an industry where human lives are directly at stake.
Far from a simple exposé, the documentary prompts viewers to confront critical questions about the corporate governance required to support innovation, the indispensable need for rigorous investor due diligence, and the call for greater transparency across the startup landscape. For healthtech professionals and anyone looking to navigate the modern startup ecosystem, it serves as an essential, cautionary case study.